Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Malignancies.

NCT01636908 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Advanced Solid Tumors

Interventions

DRUG: Sunitinib
DRUG: Sorafenib
DRUG: Erlotinib
DRUG: Everolimus
DRUG: Lapatinib
DRUG: Dasatinib
DRUG: Pazopanib
DRUG: Vemurafenib
PROCEDURE: tumor biopsy
PROCEDURE: skin biopsy (optional)

Sponsor

Amsterdam UMC, location VUmc